Our publicly available sponsored and funded datasets are listed below.
6 Datasets Available
Parkinson’s Progression Markers Initiative
The Parkinson’s Progression Markers Initiative (PPMI) is an ongoing longitudinal observational study that collects comprehensive clinical, imaging, genetic data, and biological samples.
The MJFF-sponsored online study Fox Insight collects patient reported outcome data on the lived experience of Parkinson's disease and genetic data through a collaboration with consumer genetics company 23andMe.
The Fox Investigation for New Discovery of Biomarkers (BioFIND) is an observational clinical study designed to discover and verify biomarkers of Parkinson's disease, which collected clinical data and biological samples from participants with and without Parkinson's disease.
LRRK2 Cohort Consortium
The LRRK2 Cohort Consortium (LCC) comprises three closed studies: the LRRK2 Cross-sectional Study, LRRK2 Longitudinal Study and the 23andMe Blood Collection Study. The LCC followed standardized data acquisition protocols, and clinical and genetic data as well as biological samples are stored in a comprehensive Parkinson’s database and biorepository, respectively.
Levodopa Response Trial Wearable Data
The Levodopa Response Study was designed to assess the feasibility of using wearable sensor data to estimate clinically relevant measures of the severity of Parkinson’s disease (PD) symptoms.
RNA Sequencing Project
The PPMI RNA Sequencing Project includes transcriptomics data generated from raw sequencing reads of 1,600 PPMI whole blood samples.